Description
An anticancer agent; inhibits the growth of NB4, HL-60, and U937 leukemia and primary acute myeloid leukemia cells at 5 and 10 µM; induces apoptosis in leukemia cell lines, primary AML cells, and CML cells; decreases spleen size in an HL-60 mouse xenograft model of AML in a dose-dependent manner at 50-150 mg/kg
Formal name: 3-(1,2-dihydro-2-oxo-3H-indol-3-ylidene)-1,3-dihydro-1-methyl-2H-indol-2-one
Synonyms: Methylisoindigotin
Molecular weight: 276.3
CAS: 97207-47-1
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals||Research Area|Cancer|Cell Cycle|G1||Research Area|Cancer|Cell Death|Apoptosis